Fluorescence spectroscopy (for Biologics and CGT)

Characterization of proteins, peptides in the frame of research & development, release analytics, comparability and stability studies

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.21, USP <853>, USP <1853>